牛皮和肠道微生物:研究进展从机制到治疗
Jianfei Chen1,2, Keyun Sun2, Xinyu Zhang3
1School of Traditional Chinese Medicine, Binzhou Medical University, Yantai, China.
Frontiers in microbiology
|December 22, 2025
概括
肠道微生物群失调是牛皮发育的关键因素. 针对肠-皮肤轴的疗法,如益生菌和便微生物群移植,显示出对治疗这种慢性炎症性皮肤疾病的承诺.
科学领域:
- 皮肤病学 皮肤病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 牛皮是一种慢性,免疫介导的炎症性皮肤疾病,具有复杂的发病因子.
- 肠道微生物群在牛皮发育中的作用是一个重要的研究兴趣的新兴领域.
研究的目的:
- 阐明肠道微生物群在牛皮病原发生中的作用.
- 总结基于肠道微生物群的牛皮治疗策略.
- 为牛皮研究和临床治疗提供见解.
主要方法:
- 对最近的研究文献进行系统的审查和分析.
- 专注于牛皮患者的肠道微生物群特征.
- 检查肠-皮肤轴调节机制和治疗干预措施.
主要成果:
- 与健康个体相比,牛皮患者表现出改变的肠道微生物多样性和丰富性.
- 肠道微生物通过免疫调节,肠道屏障完整性和代谢物影响牛皮.
- 基于肠道微生物群的疗法 (益生菌,益生菌,共生菌,FMT) 显示出缓解症状和减少复发的潜力.
结论:
- 肠道微生物群的失生是牛皮病原体的核心.
- 肠-皮肤轴为牛皮的多系统关联提供了新的见解.
- 基于微生物群的疗法为改善牛皮的预后提供了传统治疗的有希望的补充.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
614
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
Inflammatory Bowel Disease IV: Pharmacological Management
445
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
445
Irritable Bowel Syndrome I: Introduction
890
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
890


